COMP <GO>
TVTX vs UNH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Travere Therapeutics Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: TVTX 4
— UNH 8
■ METRIC PARITY
LAST: $49.26 (-2.24%) • MKT CAP: $4.64B
options-implied-move
—
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
options-implied-move
7.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TVTX VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TVTX | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | 88.31% | +7.69 | TVTX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.00% | 12.38% | -25.38 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.33% | 6.25% | -5.92 | UNH | /fcf-yield <GO> |
| Operating Margin | -12.80% | 5.32% | -18.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | -5.20% | 3.53% | -8.73 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 110.50% | 3.33% | +107.17 | TVTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.44 | 3.09 | +0.35 | TVTX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.1 | 55.1 | -23.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.33 | +0.75 | TVTX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.0x | 17.7x | +0.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.64B | $359.43B | -$354.79B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TVTX REV | UNH REV | TVTX GROSS % | UNH GROSS % | TVTX FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $490.7M | $447.57B | 97.9% | 88.7% | $15.7M | $16.07B |
| FY 2024 | $233.2M | $400.28B | 96.7% | 88.3% | -$248.0M | $20.70B |
| FY 2023 | $145.2M | $371.62B | — | 89.6% | -$286.6M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TVTX // BETA 1.08
UNH // BETA 0.33